NCT00489853 - Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD | Biotech Hunter

Enrollment

137

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

budesonide/formoterol Turbuhaler 320/9µg

Symbicort (budesonide/formoterol) Turbuhaler 320/9 micrograms

DRUG

formoterol Turbuhaler 9µg

Formoterol Turbuhaler 9 micrograms, 1 inhalation twice daily

OTHER

Placebo

Placebo, 1 inhalation twice daily

Trial Locations (9)

Research Site, Berlin

Research Site, Erfurt

Research Site, Fulda

Research Site, Fürth

Research Site, Geesthacht

Research Site, Grobhansdorf

Research Site, Leipzig

Research Site, Neuruppin

Research Site, Basel